Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge

Journal of Feline Medicine and Surgery

Volumn 12, Issue 6, 2010, Pages 451-457

  Huang, Chengjin ^a   Conlee, Douglas ^a   Gill, Michael ^a   Chu, Hsien Jue Steve ^a  

^a ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA; VIRUS ANTIBODY; VIRUS RNA; VIRUS VACCINE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ANIMAL EUTHANASIA; ARTICLE; BLOOD; CAT; CAT DISEASE; CD4 CD8 RATIO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; LENTIVIRUS INFECTION; LYMPH NODE; MALE; PROVIRUS; RANDOMIZED CONTROLLED TRIAL; VIROLOGY; VIRUS LOAD;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, VIRAL; CAT DISEASES; CATS; CD4-CD8 RATIO; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUTHANASIA, ANIMAL; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; LYMPH NODES; MALE; PROVIRUSES; RNA, VIRAL; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL LOAD; VIRAL VACCINES;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS;

EID: 77953082832     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.12.016     Document Type: Article

References (15)

1. Uhl E.W., Martin M., Coleman J.K., Yamamoto J.K. Advances in FIV vaccine technology. Vet Immunol Immunopathol 2008, 15:65-80.
2. Levy J.K., Scott H.M., Lachtara J.L., Crawford P.C. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 2006, 228:371-376.
3. Sellon R.K., Hartmann K. Feline immunodeficiency virus infection. Infectious diseases of the dog and cat 2006, 131-143. Saunders Elsevier, Oxford. 2nd edn. C.E. Greene (Ed.).
4. Steinrigl A., Klein D. Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics. J Gen Virol 2003, 84:1301-1307.
5. Phadke A.P., de la Concha-Bermejillo A., Wolf A.M., Andersen P.R., Baladandayuthapani V., Collisson E.W. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B. Vet Microbiol 2006, 115:64-76.
6. Klonjkowski B., Klein D., Galea S., et al. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS. Vaccine 2009, 27:928-939.
7. Hohdatsu T., Okada S., Motokawa K., Aizawa C., Yamamoto J.K., Koyama H. Effect of dual-subtype vaccine against feline immunodeficiency virus infection. Vet Microbiol 1997, 58:155-165.
8. Pu R., Coleman J., Omori M., et al. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 2001, 15:1225-1237.
9. Huang C., Conlee D., Loop J., Champ D., Gill M., Chu H.J. Efficacy and safety of a feline immunodeficiency virus vaccine. Anim Health Res Rev 2004, 5:295-300.
10. Kusuhara H., Hohdatsu T., Okumura M., et al. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet Microbiol 2005, 108:155-165.
11. Pu R., Coleman J., Coisman J., et al. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate. J Feline Med Surg 2005, 7:65-70.
12. Tompkins M.B., Ogilvie G.K., Franklin R.A., Kelley K.W., Tompkins W.A. Induction of IL-2 and lymphokine activated killer cells in the cat. Vet Immunol Immunopathol 1987, 16:1-10.
13. Willett B.J., Hosie M.J., Callanan J.J., Neil J.C., Jarrett O. Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunol 1993, 78:1-6.
14. Omori M., Pu R., Tanabe T., et al. Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine. Vaccine 2004, 23:386-398.
15. Yamamoto J.K., Pu R., Sato E., Hohdatsu T. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 2007, 15:1225-1237.